bluuebunny/crossref_metadata_2025_split huggingface dataset:
Multi-Scale Pore Structure Characterization of Silurian Marine Shale and Its Coupling Relationship With Material Composition: A Case Study in the Northern Guizhou Area
Authors: Du Wei , Lin Ruiqin , Shi Fulun , Luo Nina , Wang Yisong , Fan Qingqing , Cai Junying , Zhang Ziya , Liu Li , Yin Wei , Zhao Fuping , Sun Zhao , Chen Yi 
Published: July 2022

Investigation of pore structure is vital for shale reservoir evaluation and also “sweet spot” prediction. As the strong heterogeneity in pore types, morphology, and size distributions of organic matter-rich shales, it is essential to combine different approaches to comprehensively characterize them.Field emission-scanning electron microscopy (FE-SEM), low-pressure gas (CO2 and N2) adsorption, and high-pressure mercury intrusion (HPMI) were employed to systematically investigate the pore structure of the lower Longmaxi shale reservoirs in the northern Guizhou area. The results show that the shales can be divided into four lithofacies based on mineral composition, namely, siliceous shale (SS), clay shale (CS), carbonate shale (CAS), and mixed shale (MS), among which siliceous shale is the primary lithofacies of the Longmaxi shale. Numerous organic matter (OM)-hosted pores, clay interlayer pores, interparticle pores, and intraparticle pores were identified within shale reservoirs. The specific surface area ranges from 11.3 to 27.4 m2/g, with an average of 18.1 m2/g. It exhibits a strong positive correlation with TOC contents, suggesting that organic matter is the major contributor to the specific surface areas. A wide range of pore size distribution was measured by integration of gas adsorption and HPMI. It is shown that the pore size is primarily distributed within ∼100 nm, corresponding to micropores, mesopores, and part of macropores. The total pore volume, which is mostly derived from the contribution of micropores and mesopores, remains within a range of 0.11 to 0.025 ml/g, with an average of 0.018 ml/g. Furthermore, the volume of micropores and mesopores is mainly controlled by organic matter contents. The dissolution pore contributes most to the macropore space within shale reservoirs, based on the positive correlation with macropore volume and easily dissolved minerals, including carbonate and feldspar. Also, the total pores volume is mainly dominated by organic matter and carbonate contents. This is possibly attributed to the easily dissolved and rigid features of carbonate, which can protect the primary interparticle pores due to its high compression resistance and is conducive to forming abundant dissolution pores. OM-rich carbonate-bearing mixed shale may be the most favorable lithofacies for gas storage in the northern Guizhou area.
Finite Element Analysis of Osteoporotic and Osteoblastic Vertebrae and Its Association With the Proton Density Fat Fraction From Chemical Shift Encoding-Based Water-Fat MRI – A Preliminary Study
Authors: Greve Tobias , Rayudu Nithin Manohar , Dieckmeyer Michael , Boehm Christof , Ruschke Stefan , Burian Egon , Kloth Christopher , Kirschke Jan S. , Karampinos Dimitrios C. , Baum Thomas , Subburaj Karupppasamy , Sollmann Nico 
Published: July 2022

PurposeOsteoporosis is prevalent and entails alterations of vertebral bone and marrow. Yet, the spine is also a common site of metastatic spread. Parameters that can be non-invasively measured and could capture these alterations are the volumetric bone mineral density (vBMD), proton density fat fraction (PDFF) as an estimate of relative fat content, and failure displacement and load from finite element analysis (FEA) for assessment of bone strength. This study’s purpose was to investigate if osteoporotic and osteoblastic metastatic changes in lumbar vertebrae can be differentiated based on the abovementioned parameters (vBMD, PDFF, and measures from FEA), and how these parameters correlate with each other.Materials and MethodsSeven patients (3 females, median age: 77.5 years) who received 3-Tesla magnetic resonance imaging (MRI) and multi-detector computed tomography (CT) of the lumbar spine and were diagnosed with either osteoporosis (4 patients) or diffuse osteoblastic metastases (3 patients) were included. Chemical shift encoding-based water-fat MRI (CSE-MRI) was used to extract the PDFF, while vBMD was extracted after automated vertebral body segmentation using CT. Segmentation masks were used for FEA-based failure displacement and failure load calculations. Failure displacement, failure load, and PDFF were compared between patients with osteoporotic vertebrae versus patients with osteoblastic metastases, considering non-fractured vertebrae (L1-L4). Associations between those parameters were assessed using Spearman correlation.ResultsMedian vBMD was 59.3 mg/cm3 in osteoporotic patients. Median PDFF was lower in the metastatic compared to the osteoporotic patients (11.9% vs. 43.8%, p=0.032). Median failure displacement and failure load were significantly higher in metastatic compared to osteoporotic patients (0.874 mm vs. 0.348 mm, 29,589 N vs. 3,095 N, p=0.034 each). A strong correlation was noted between PDFF and failure displacement (rho -0.679, p=0.094). A very strong correlation was noted between PDFF and failure load (rho -0.893, p=0.007).ConclusionPDFF as well as failure displacement and load allowed to distinguish osteoporotic from diffuse osteoblastic vertebrae. Our findings further show strong associations between PDFF and failure displacement and load, thus may indicate complimentary pathophysiological associations derived from two non-invasive techniques (CSE-MRI and CT) that inherently measure different properties of vertebral bone and marrow.
Bioinformatics Analysis Identifies Potential Ferroptosis Key Gene in Type 2 Diabetic Islet Dysfunction
Authors: Ye Haowen , Wang Ruxin , Wei Jinjing , Wang Ying , Zhang Xiaofang , Wang Lihong 
Published: July 2022

BackgroundIslet β cells dysfunction (IBCD) is a cortical component in pathogenesis of type 2 diabetic mellitus (T2DM). However, the relationship of ferroptosis and IBCD remains unknown. This study was aimed to screen potential ferroptosis key genes to reveal latent physiological and pathological process of IBCD in T2DM.MethodsFirstly, T2DM key genes were screened by combining with differentially expressed genes (DEGs) analysis and WGCNA. Then, ferroptosis-related genes (FRGs) in IBCD of T2DM were identified by taking the intersection between T2DM key genes and FRGs. Finally, T2DM-FRGs were validated in another T2DM dataset as well as islet single-cell RNA sequencing dataset and the miRNA regulated T2DM-FRG was predicted by using four miRNA databases.Results89 T2DM key genes were identified between DEGs and WGCNA. Then, 3 T2DM-FRGs were screened by taking the intersection of T2DM key genes and FRGs, namely ITGA6, MGST1 and ENO2. At last, MGST1 were validated as the T2DM-FRG in another T2DM islet issues dataset and islet single-cell RNA sequencing dataset.ConclusionMGST1 may be the potential ferroptosis key gene of IBCD in T2DM.
Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials
Authors: Hu Weiting , Song Rui , Cheng Rui , Liu Caihong , Guo Rui , Tang Wei , Zhang Jie , Zhao Qian , Li Xing , Liu Jing 
Published: July 2022

The association between glucagon-like peptide-1 (GLP-1) receptor agonists and the risk of various kinds of thyroid disorders remains uncertain. We aimed to evaluate the relationship between the use of GLP-1 receptor agonists and the occurrence of 6 kinds of thyroid disorders. We searched PubMed (MEDLINE), EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL) and Web of Science from database inception to 31 October 2021 to identify eligible randomized controlled trials (RCTs). We performed meta-analysis using a random-effects model to calculate risk ratios (RRs) and 95% confidence intervals (CIs). A total of 45 trials were included in the meta-analysis. Compared with placebo or other interventions, GLP-1 receptor agonists’ use showed an association with an increased risk of overall thyroid disorders (RR 1.28, 95% CI 1.03-1.60). However, GLP-1 receptor agonists had no significant effects on the occurrence of thyroid cancer (RR 1.30, 95% CI 0.86-1.97), hyperthyroidism (RR 1.19, 95% CI 0.61-2.35), hypothyroidism (RR 1.22, 95% CI 0.80-1.87), thyroiditis (RR 1.83, 95% CI 0.51-6.57), thyroid mass (RR 1.17, 95% CI 0.43-3.20), and goiter (RR 1.17, 95% CI 0.74-1.86). Subgroup analyses and meta-regression analyses showed that underlying diseases, type of control, and trial durations were not related to the effect of GLP-1 receptor agonists on overall thyroid disorders (all P subgroup &gt; 0.05). In conclusion, GLP-1 receptor agonists did not increase or decrease the risk of thyroid cancer, hyperthyroidism, hypothyroidism, thyroiditis, thyroid mass and goiter. However, due to the low incidence of these diseases, these findings need to be examined further.Systematic Review RegistrationPROSPERO https://www.crd.york.ac.uk/prospero/, identifier: CRD42021289121.
Spatio-Temporal Evolution of Sandy Land and its Impact on Soil Wind Erosion in the Kubuqi Desert in Recent 30 Years
Authors: Dang Xiaohong , Na Ya , Chi Wenfeng , Zhao Jiangjia , Zhao Yuanyuan , Wang Yue , Wu Xiaoguang , Wang Yuetian 
Published: July 2022

Continuous remote-sensing monitoring of sand in desert areas and the exploration of the spatio–temporal evolution characteristics of soil–wind erosion has an important scientific value for desertification prevention and ecological restoration. In this study, the Kubuqi Desert was selected as the study area, and the Landsat series satellite remote sensing data, supplemented by satellite remote sensing data such as GE images, SPOT-5, ZY-3, GF-1/2/6, etc., integrated object-oriented, decision tree, and auxiliary human–computer interaction interpretation methods, developed the Kubuqi Desert area dataset from 1990 to 2020, and established a soil erosion intensity database of the past 30 years based on the soil–wind erosion correction equation. The results show that the application of the training samples obtained by a high-score collaborative ground sampling to land use/cover classification in desert areas can effectively improve the efficiency of remote-sensing mapping of sand changes and the accuracy of change information identification, and the overall accuracy of the classification results is 95%. In general, the sandy area of the Kubuqi Desert area has decreased year by year, during which the mobile sand in the hinterland of the desert has expanded in a scattered distribution. The overall soil–wind erosion intensity showed a downward trend, especially since 2000; the ecological improvement trend after the implementation of desertification control projects is obvious. Changes in the sand type contributed the most to the reduction of soil–wind erosion intensity (contribution 81.14%), ecological restoration played a key role in reducing the soil–wind erosion intensity (contribution 14.42%), and the increase of forest and grass vegetation covers and agricultural oases played a positive role in solidifying the soil- and wind-proof sand fixation. The pattern of sandy land changes in desert areas is closely related to the national ecological civilization construction policy and the impact of climate change.
Cytoplasmic Injection of Zygotes to Genome Edit Naturally Occurring Sequence Variants Into Bovine Embryos
Authors: Wei Jingwei , Brophy Brigid , Cole Sally-Ann , Moormann Jannis , Boch Jens , Laible Gӧtz 
Published: July 2022

Genome editing provides opportunities to improve current cattle breeding strategies through targeted introduction of natural sequence variants, accelerating genetic gain. This can be achieved by harnessing homology-directed repair mechanisms following editor-induced cleavage of the genome in the presence of a repair template. Introducing the genome editors into zygotes and editing in embryos has the advantage of uncompromised development into live animals and alignment with contemporary embryo-based improvement practices. In our study, we investigated the potential to introduce sequence variants, known from the pre-melanosomal protein 17 (PMEL) and prolactin receptor (PRLR) genes, and produce non-mosaic, edited embryos, completely converted into the precision genotype. Injection of gRNA/Cas9 editors into bovine zygotes to introduce a 3 bp deletion variant into the PMEL gene produced up to 11% fully converted embryos. The conversion rate was increased to up to 48% with the use of TALEN but only when delivered by plasmid. Testing three gRNA/Cas9 editors in the context of several known PRLR sequence variants, different repair template designs and delivery as DNA, RNA or ribonucleoprotein achieved full conversion rates up to 8%. Furthermore, we developed a biopsy-based screening strategy for non-mosaic embryos which has the potential for exclusively producing non-mosaic animals with intended precision edits.
Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD
Authors: Lin Liuyu , Wu Yuqing , Hang Hailun , Lu Jie , Ding Yuanliang 
Published: July 2022

Background and ObjectiveNeuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody (MOG-IgG) associated disease (MOGAD) are autoimmune inflammatory demyelinating diseases of the central nervous system (CNS). As the clinical features of NMOSD are similar to MOGAD, diagnostic confusion exists between the two diseases. To better discriminate NMOSD from MOGAD, we investigated whether the plasma levels of complement 3 (C3) and complement 4 (C4) are different in NMOSD and MOGAD during the acute attacks of the diseases. We sought to determine whether C3 or C4 has an influence on the features of NMOSD.MethodsIn this observational study, data from 73 aquaporin-4 antibodies (AQP4-IgG) positive NMOSD patients and 22 MOG-IgG positive MOGAD patients were collected retrospectively. Demographics, clinical characteristics, plasma parameters, and cerebrospinal fluid (CSF) findings will be analyzed for comparability between the two groups. Immunoglobulin-G (IgG) and albumin were measured in both plasma and CSF. Plasma levels of C3 and C4 were measured and compared between the NMOSD, MOGAD, and 42 healthy controls (HC). The correlations between plasma C3, C4, and NMOSD clinical parameters were analyzed.ResultsThe ages of onset were later in the AQP4-IgG positive NMOSD group and females predominated, which differed from the MOGAD group, whose ages were younger and with a slight male preponderance. The AQP4-IgG positive NMOSD patients presented with the clinical symptoms of optic neuritis (ON) and transverse myelitis (TM), whereas encephalitis symptoms were more prevalent in MOGAD patients. CSF analysis shows that slight but not significantly higher white cell count (WCC) and protein were observed in the MOGAD group than in the AQP4-IgG positive NMOSD group. The plasma levels of IgG in MOGAD patients are significantly lower (p = 0.027) than in NMOSD patients. On the contrary, the plasma levels of albumin in MOGAD were higher than in NMOSD, which reached statistical significance (p = 0.039). Both the plasma C3 and C4 levels in the NMOSD group were significantly lower than in MOGAD and HC. The receiver operating characteristic (ROC) curve of the prediction model comprises C3 and C4 to distinguish NMOSD from MOGAD [area under the curve (AUC): 0.731, 0.645], which are considered to have discriminatory values. The results of Spearman’s analysis revealed that there was a significant positive correlation between the plasma C3 and the CSF WCC (r = 0.383, p = 0.040). There was an inverse correlation between plasma C4 and plasma IgG (r = -0.244, p = 0.038). Plasma C3 or C4 was significantly positively correlated with CSF albumin and Q-Alb, which is considered a measure of blood-brain barrier (BBB) disruption.ConclusionDuring the acute phase of NMOSD and MOGAD, plasma C3 and C4 may become potential biomarkers for distinguishing the two diseases and reflecting the NMOSD BBB damage.
Early Expression of Functional Markers on CD4+ T Cells Predicts Outcomes in ICU Patients With Sepsis
Authors: Chen Jianwei , Wang Hao , Guo Ran , Li Haolong , Cui Na 
Published: July 2022

ObjectiveThere is evidence that metabolic disorder, dysfunction and abnormal apoptosis of immune cells are closely related to immunosuppression in sepsis. Single monitoring of exhaustion receptors does not reflect well the immune status of septic patients; therefore, we monitored immune status in relation to metabolism, function and apoptosis of immune cells to find good prognostic indicators for sepsis.DesignA single-center prospective observational study.SettingTeaching hospital including an academic tertiary care center.Patients81 patients with sepsis and 22 without sepsis admitted to the ICU.InterventionsPatients were divided according to Sequential Organ Failure Assessment (SOFA) score: mild sepsis 2–5 points and severe sepsis ≥6 points. SOFA score was recalculated daily. If it changed by ≥2 points within 2 days, T-cell metabolism, function and apoptotic makers [mammalian target of rapamycin (mTOR), T-bet, interferon (IFN)-γ, granzyme B, and programmed cell death (PD)-1] were continuously monitored on days 1, 3 and 5 after admission.Measurements and Main ResultsThe overall status of immune cells was compared among patients with different severity of sepsis. Patients with severe sepsis, compared with mild and no sepsis, had lower lymphocyte counts, higher expression of receptors associated with cell metabolism, activation and apoptosis, and lower expression of functional receptors. Multivariate regression analysis revealed that frequency of CD4+ T cells expressing mTOR, IFN-γ and PD-1 at admission was an independent predictor of 28-day mortality. Receiver operating characteristic curve analysis indicated that frequency of CD4+ T cells expressing mTOR, IFN-γ and PD-1 predicted 28-day mortality, with cutoffs of 30.57%, 12.81% and 22.46%, respectively. The expression of related receptors on CD8+ T cells showed similar trend to that on CD4+ T cells, but no significant difference was found.ConclusionsAbnormally increased expression of metabolic and apoptotic receptors on CD4+ T cells and decreased expression of functional factors are associated with poor prognosis in ICU patients with sepsis. Poor prognosis can be identified by early detection of expression of mammalian target of rapamycin (mTOR), IFN-γ and PD-1 on CD4+ T cells.
Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial
Authors: Liang Xuelei , Chang Yuan , Wu Haixuan , Liu Yi , Zhao Jian , Wang Leyi , Zhuo Fenglin 
Published: July 2022

BackgroundThe efficacy of topical minoxidil (MX) alone on female pattern hair loss (FPHL) is limited. Combination therapy based on topical MX is currently expected to provide better outcomes.ObjectivesThis study aimed to assess whether the combined therapies including MX plus oral spironolactone (SPT) and MX plus microneedling (MN) have advantages in efficacy and safety over topical MX alone on mild-to-moderate FPHL with normal hormone levels in the blood and regular menstrual cycle.MethodsA prospective, single-center, parallel-group, evaluator blinded, randomized trial including 120 non-menopause women with proven FPHL (Sinclair class II-III) was performed in China. Patients were randomly assigned to three groups, namely, the MX group (5% topical MX alone, once daily), the MX + SPT group (MX plus SPT 80–100 mg daily), and the MX+MN group (MX plus MN every 2 weeks, 12 sessions). The change from the baseline to week 24 was assessed in hair growth (hair density and diameter under dermoscope), scalp tissue structure (epidermal thickness, dermis thickness, and average hair follicle diameter under ultrasound biomicroscopy), physician's global assessment (using a 7-point global-assessment scale and Sinclair's stage change), patient evaluation (Women's Androgenetic Alopecia Quality of Life Questionnaire and Sinclair's hair-shedding score) and side effects.ResultsIn total, 115 participants completed the trial. At week 24, the hair density increased most in MX + MN group and increased least in MX group (p &lt; 0.001 for MX + MN group vs. MX + SPT group; p = 0.009 for MX + SPT group vs. MX group). The hair shaft diameter significantly increased in all groups (p &lt; 0.001, respectively), but there were no significant differences among the three groups (p = 0.905). The epidermal thickness and average hair follicle diameter only increased in MX + MN group. Dermis thickness increased in all groups, but there were no significant differences among the three groups. Both physician's and patient assessments showed improvement in all three groups. Scalp pruritus was the most common side effect. The MX + SPT group had the most reported adverse effects.LimitationsThe main limitations of this study are the relatively small sample size, the exclusion of severe FPHL patients, and the potential bias from unblinded treatments among the 3 groups.ConclusionTopical MX combined with MN is a better choice than either MX plus oral SPT or MX alone for the treatment of mild-to-moderate FPHL patients.
Remote Patient Management May Reduce All-Cause Mortality in Patients With Heart-Failure and Renal Impairment
Authors: Naik Marcel G. , Budde Klemens , Koehler Kerstin , Vettorazzi Eik , Pigorsch Mareen , Arkossy Otto , Stuard Stefano , Duettmann Wiebke , Koehler Friedrich , Winkler Sebastian 
Published: July 2022

BackgroundRemote patient management (RPM) in heart failure (HF) patients has been investigated in several prospective randomized trials. The Telemedical Interventional Management in Heart Failure II (TIM-HF2)-trial showed reduced all-cause mortality and hospitalizations in heart failure (HF) patients using remote patient management (RPM) vs. usual care (UC). We report the trial's results for prespecified eGFR-subgroups.MethodsTIM-HF2 was a prospective, randomized, controlled, parallel-group, unmasked (with randomization concealment), multicenter trial. A total of 1,538 patients with stable HF were enrolled in Germany from 2013 to 2017 and randomized to RPM (+UC) or UC. Using CKD-EPI-formula at baseline, prespecified subgroups were defined. In RPM, patients transmitted their vital parameters daily. The telemedical center reviewed and co-operated with the patient's General Practitioner (GP) and cardiologist. In UC, patients were treated by their GPs or cardiologist applying the current guidelines for HF management and treatment. The primary endpoint was the percentage of days lost due to unplanned cardiovascular hospitalizations or death, secondary outcomes included hospitalizations, all-cause, and cardiovascular mortality.ResultsOur sub analysis showed no difference between RPM and UC in both eGFR-subgroups for the primary endpoint (&lt;60 ml/min/1.73 m2: 40.9% vs. 43.6%, p = 0.1, ≥60 ml/min/1.73 m2 26.5 vs. 29.3%, p = 0.36). In patients with eGFR &lt; 60 ml/min/1.73 m2, 1-year-survival was higher in RPM than UC (89.4 vs. 84.6%, p = 0.02) with an incident rate ratio (IRR) 0.67 (p = 0.03). In the recurrent event analysis, HF hospitalizations and all-cause death were lower in RPM than UC in both eGFR-subgroups (&lt;60 ml/min/1.73 m2: IRR 0.70, p = 0.02; ≥60 ml/min/1.73 m2: IRR 0.64, p = 0.04). In a cox regression analysis, age, NT-pro BNP, eGFR, and BMI were associated with all-cause mortality.ConclusionRPM may reduce all-cause mortality and HF hospitalizations in patients with HF and eGFR &lt; 60 ml/min/1.73 m2. HF hospitalizations and all-cause death were lower in RPM in both eGFR-subgroups in the recurrent event analysis. Further studies are needed to investigate and confirm this finding.